CSF2 and pancreatic neoplasm: A randomized clinical trial with administration of a granulocyte-macrophage colony-stimulating factor (GM-CSF)-allogeneic pancreatic tumor cell vaccine (GVAX) demonstrated the induction of mature TLS formation alone or in combination with low dose cyclophosphamide (134).